NHS England
The main aim of NHS England is to improve the health outcomes for people in England. They believe the new approach they are taking will really make a difference and deliver the improved health outcomes they all want to see. Central to their ambition is to place the patients and the public at the heart of everything they do. They are what they want the NHS to be – open, evidence-based and inclusive, to be transparent about the decisions they make, the way they operate and the impact they have. They encourage patient and public participation in the NHS, treat them respectfully and put their interests first. This allows us to develop the insight to help us improve outcomes and guarantee no community is left behind or disadvantaged. They empower and support clinical leaders at every level of the NHS through clinical commissioning groups (CCGs), networks and senates, in NHS England itself and in providers, helping them to make genuinely informed decisions, spend the taxpayers’ money wisely and provide high quality services. Engaging with their staff is equally important to us too. Their staff are what makes NHS England an excellent organisation: an exemplar in customer focus, professionalism, rigour and creativity. Grounded by the values and principles of the NHS Constitution, they are an organisation who shares ideas and knowledge, successes and failures, and listens to each other carefully and thoughtfully. At NHS England, they practice what they preach. By working collaboratively and building coalitions with partners everywhere means they can achieve greater things together and deliver the best patient service not only in England but in the world.
Ibex Medical Analytics was conceived when its two founders were looking for ways to apply their skills to contribute to human well-being. They were captivated with the opportunity presented by applying artificial intelligence (AI) to medicine and, in particular, the potential it holds for advancing cancer care. They decided to combine their accumulated knowledge of AI, data science, image analysis, and machine learning, and apply it to cancer diagnostics in digital pathology. Today, Ibex is a multidisciplinary team comprised of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: Applying AI to cancer diagnostics, striving to improve patient outcomes and quality of life.
Tommy's is a charity that carries out research into the causes of miscarriage, stillbirth, and premature birth. They support them throughout their entire pregnancy journey from conception to postpartum recovery. Their free digital tools, calculators, and resources will help them have a healthy and happy pregnancy. All the information and support they need, including tools and news, and stories covering the entire pregnancy.
Royal United Hospital Bath NHS Foundation Trust provides acute treatment and cares for people in Bath and the surrounding towns.
Cibiltech develops digital solutions for predictive medicine in renal transplantation. Cibiltech's algorithm helps nephrologists to better assess individual graft loss trajectory for each patient and to adjust treatment accordingly. This results in longer survival of the graft, an extended patient lifespan, and better clinical resources management.
Medtronic provides healthcare technology solutions for complex and challenging conditions. They deliver treatments and therapies for the lungs, brain, dental, diabetes, ENT, heart, gastrointestinal, orthopedic, urinary, and women's health. The company's technologies and therapies treat 70 different medical conditions and include patient monitoring systems, robotic surgery, insulin pumps, cardiac devices, and more. Medtronic delivers innovative technologies that change people's lives through to its extensive knowledge, insatiable curiosity, and desire to assist everyone in need.
icometrix provides clinicians with standardized measurements on their patients’ brain MRI scans in order to improve personalized care of people with a neurological disorder. icometrix was founded in 2011 by Dirk Loeckx and Wim Van Hecke. It is a spin-off company of the universities and university hospitals of Leuven and Antwerp. Today, icometrix has grown to a team of over 25 people and is internationally active, with headquarters in Leuven and an office in Boston, USA. They are the worldwide standard in MRI biomarkers in routine clinical practice. icometrix developed MSmetrix, which detects brain lesions, calculates lesion volume and measures the whole brain and grey matter volume and atrophy. MSmetrix, received market approval in the EU and other countries including Canada, Brazil and Australia. FDA clearance is pending. Furthermore, icometrix is ISO9001 and ISO13485 (Medical Devices) and ISO27001 (Information Security) certified. icometrix also acts as an image analysis expert in clinical trials and research studies. Imaging biomarkers constantly lead to new insights on neurological disorders. Since recently, imaging biomarker outcomes often serve as the primary endpoints in clinical trials for the development of new drugs. For these purposes large batches of brain imaging data are frequently transferred to icometrix for fast and high quality processing. This way our software-as-a-service is incorporated in clinical trials and large research studies regarding Traumatic Brain Injury (TBI), Epilepsy, Alzheimer’s Disease, Stroke, etc.
InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery. ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.
Optos plc has the vision to be The retina company. We aim to be recognised as a leading provider of devices and solutions to eyecare professionals for improved patient care. Optos' core devices produce ultra widefield, high resolution digital images (optomaps) of approximately 82% of the retina, something no other device is capable of doing in any one image. Optos has a range of imaging devices that support different customer segments and patient levels: the P200 and 200Dx devices are concentrated on wellness screening carried out by optometrists and ophthalmologists in primary care; the P200C devices are designed to meet the need for more exacting clinical imaging capabilities and standards in secondary care within the ophthalmology market and at optometric practices that are clinically managing a patient base with advanced ocular disease; and the P200MA and 200Tx devices supports ophthalmologists and retinal specialists in the medical care market.
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical techniques with Pyxus. The only take home simulator that includes lap appendectomy and cholecystectomy training models.
Corporation Pop designs original and engaging interactive tools that help their clients communicate with their audience. Founded in 2007, the company is headquartered in Manchester, Manchester, United Kingdom.
Non Equity Assistance in 2014
Blue Maestro is a leading designer and developer of connected products and solutions, from consumer devices through to their work with NHS England on the next generation of medicine adherence sensors. They have a number of innovative products and solutions under development, several that are patent pending. Meet some of Blue Maestro’s management team below.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.